Clonidine Versus Adenosine to Treat Neuropathic Pain
Completed · Phase 2 · Has a placebo group
Conditions studied: Pain
In brief
The purpose of this study is to determine the effects of clonidine and adenosine on nerve pain.
Key facts
- Study ID
- NCT00349921
- Run by
- Wake Forest University Health Sciences
- People needed
- 24
- Starts
- 2004-08-01
- Expected to finish
- 2008-01-01
- Last updated by the study team
- 2018-09-10
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with complex regional pain syndrome (CRPS), type I involving a lower extremity
You may not qualify if…
- Pregnancy
- Allergy to clonidine
- Currently taking clonidine or other direct a2-adrenergic agonists, or taking cholinesterase inhibitors
- Patients with any serious or unstable medical problems (heart, lung, liver, kidney, or nervous system disease)
Where it is running
- The Center for Clinical Research, 145 Kimel Park Drive — Winston-Salem, North Carolina, United States
- Wake Forest University School of Medicine, Medical Center Boulevard — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.